MedPath

To a Sustainable Quality Policy

Not Applicable
Conditions
Management Systems
Quality Improvement
Public Health
Interventions
Other: Implementation of a quality indicator feedback mechanism
Registration Number
NCT04200209
Lead Sponsor
KU Leuven
Brief Summary

The investigators need stronger feedback loops and a quality monitoring and management system to improve the quality of care in sustainable way. The Chair Sint-Trudo "To a sustainable quality policy" was established to scientifically develop prerequisites for a sustainable quality of care. In this study protocol, a monocentric mixed-method quasi-experimental study will be used to assess the impact of a rapid-cycle quality indicator feedback mechanism on both patients and professionals.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
400
Inclusion Criteria
  • Patients admitted in the hospital for more than one night
Exclusion Criteria
  • Patients admitted in the hospital for less than one night

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
HospitalImplementation of a quality indicator feedback mechanismTwelve wards of the hospital will be evaluated at the same time.
Primary Outcome Measures
NameTimeMethod
Hospital mortalityDuring admission

In-hospital mortality rate

Failure to rescue rateDuring admission

The failure to rescue rate for each patient admitted in the hospital will be evaluated

Readmission rate30 days after discharge

Readmission within 30 days of each patient admitted in the hospital

Patient experiencesDuring admission

Experiences of patients will be measures by a validated questionnaire (Flemisch Patient Experience Questionnaire).

Q: Will you recommend our hospital? (scale min 0 until 10 with 0: not and 10: for sure).

For follow questions the scores are 'disagree', 'somewhat agree', 'largely agree', 'totally agree. The higher the score the better the outcome Q: This information was provided by my GP or by healthcare providers in the hospital.

Q: I understand the information I received about the cost of my stay. Q: I received sufficient information about the causes of my condition or about the possible treatment methods for my condition or about the consequences of my disease.

Q: Nurses or doctors explained things in a way I could understand or treated me with courtesy and respect.

Q: My privacy was respected during conversations with caregivers or during examinations, treatment and care.

Q: Before any treatment my identity was checked. Q: Hospital staff always introduced themselves

In-hospital length of stayDuring admission

Length of stay of each patient in the hospital

Adverse events and adverse outcomesDuring admission

Each adverse event and following adverse outcomes will be measured: urinary tract infections, pressure ulcers, hospital-acquired pneumonia, shock/cardiac arrest, upper-gastrointestinal bleeding, hospital-acquired sepsis, deep venous thrombosis, central nervous system complications, surgical wound infection, pulmonary failure, metabolic derangement, methicillin-resistant Staphylococcus aureus, vancomycin resistant Enterococcus, central line associated bloodstream infections, carbapenemase producing Enterobacteriaceae

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sint-Trudo Ziekenhuis

🇧🇪

Sint-Truiden, Belgium

© Copyright 2025. All Rights Reserved by MedPath